Acromegaly Suspended Phase 1 Trials for Octreotide (DB00104)
Also known as: Acromegalic / Acromegaly (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0000951 (Acromegaly) | Suspended | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01086982 | Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ® | Treatment |